{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T21:56:56Z","timestamp":1777586216425,"version":"3.51.4"},"reference-count":59,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:00:00Z","timestamp":1759536000000},"content-version":"unspecified","delay-in-days":95,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["10330032010007"],"award-info":[{"award-number":["10330032010007"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Neurol Open"],"accepted":{"date-parts":[[2025,9,22]]},"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Statin therapy is known to reduce subsequent cardiovascular events in patients who had an ischaemic stroke and transient ischaemic attack (TIA). However, its effectiveness and safety in frail older adults with a recent stroke or TIA are uncertain, leading to variations in clinical practice. \u2018StAtins in Frail oldEr patients with ischemic Stroke or Transient ischemic attack\u2013the Randomized Controlled Trial\u2019 (SAFEST-RCT) aims to investigate the effectiveness of initiating versus not initiating statin therapy in this vulnerable population, to optimise secondary prevention strategies.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and analysis<\/jats:title>\n                  <jats:p>This multicentre, prospective, randomised, open-label study aims to enrol 612 frail adults \u226570 years with a recent acute ischaemic stroke or TIA across 22 Dutch hospitals. The study compares prescribing versus not prescribing statins in terms of health-related quality of life, major adverse cardiovascular event-free survival and societal costs over a 2-year follow-up period.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Ethics and dissemination<\/jats:title>\n                  <jats:p>The SAFEST-RCT protocol was approved by the Ethics Committee of Amsterdam UMC. It complies with the Declaration of Helsinki and is classified as a healthcare evaluation. Recruitment began in March 2025. Results will be published in open access journals, presented at conferences, shared via the Dutch Brain Injury Association and integrated into national guidelines to support implementation in routine care.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration number<\/jats:title>\n                  <jats:p>\n                     <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT06785727\">NCT06785727<\/jats:ext-link>.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjno-2025-001297","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:20:19Z","timestamp":1759731619000},"page":"e001297","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Rationale and design of \u2018StAtins in Frail oldEr patients with ischemic Stroke or Transient ischemic attack\u2013the Randomized Controlled Trial\u2019 (SAFEST-RCT)"],"prefix":"10.1136","volume":"7","clinical-trial-number":[{"clinical-trial-number":"nct06785727","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct06785727","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9940-1930","authenticated-orcid":false,"given":"Susanna Rosa","family":"Prins","sequence":"first","affiliation":[{"name":"Department of Neurology, Amsterdam UMC Locatie AMC, Amsterdam, Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgit A","family":"Damoiseaux-Volman","sequence":"additional","affiliation":[{"name":"Department of Medical Informatics, Amsterdam UMC, Amsterdam, Netherlands"},{"name":"Amsterdam Public Health Research Institute, University of Amsterdam, Amsterdam, Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah E","family":"Vermeer","sequence":"additional","affiliation":[{"name":"Department of Neurology, Rijnstate Hospital, Arnhem, Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick M M","family":"Bossuyt","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Data Science, Amsterdam Public Health Research Institute, Amsterdam, Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rik","family":"Van Eekelen","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Data Science, Amsterdam Public Health Research Institute, Amsterdam, Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith E","family":"Bosmans","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Amsterdam Public Health Research Institute, Amsterdam, Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eveline P","family":"Van Poelgeest","sequence":"additional","affiliation":[{"name":"Amsterdam Public Health Research Institute, University of Amsterdam, Amsterdam, Netherlands"},{"name":"Expertise Centre for Pharmacotherapy in Older People (Ephor), Amsterdam, Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrice M A C","family":"Martens","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Amsterdam UMC Locatie AMC, Amsterdam, Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marielle H","family":"Emmelot-Vonk","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, University Medical Center Utrecht, Utrecht, Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Verstraete","sequence":"additional","affiliation":[{"name":"Department of Neurology, Rijnstate Hospital, Arnhem, Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majon","family":"Muller","sequence":"additional","affiliation":[{"name":"Departments of Internal Medicine and Geriatrics, Amsterdam UMC, Amsterdam, Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric P","family":"Moll Van Charante","sequence":"additional","affiliation":[{"name":"Department of General Practice, Amsterdam UMC, Amsterdam, Netherlands"},{"name":"Department of Public and Occupational Health, Amsterdam UMC, Amsterdam, Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiel","family":"Lindhout","sequence":"additional","affiliation":[{"name":"Dutch Brain Injury Association (Hersenletsel.nl), Velp, Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Van Der Velde","sequence":"additional","affiliation":[{"name":"Amsterdam Public Health Research Institute, University of Amsterdam, Amsterdam, Netherlands"},{"name":"Departments of Internal Medicine and Geriatrics, Amsterdam UMC, Amsterdam, Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renske M","family":"Van Den Berg-Vos","sequence":"additional","affiliation":[{"name":"Department of Neurology, Amsterdam UMC Locatie AMC, Amsterdam, Netherlands"},{"name":"Department of Neurology, OLVG Hospital, Amsterdam, Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,10,5]]},"reference":[{"key":"2025100523201345000_7.2.e001297.1","doi-asserted-by":"publisher","DOI":"10.1177\/17474930211065917"},{"key":"2025100523201345000_7.2.e001297.2","doi-asserted-by":"crossref","unstructured":"Cheng Y , Lin Y , Shi H , et al . Projections of the stroke burden at the global, regional, and national levels up to 2050 based on the global burden of disease study 2021. J Am Heart Assoc 2024;13. doi:10.1161\/JAHA.124.036142","DOI":"10.1161\/JAHA.124.036142"},{"key":"2025100523201345000_7.2.e001297.3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/ijerph18147552","article-title":"Economic burden of stroke disease: a systematic review","volume":"18","author":"Rochmah","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"2025100523201345000_7.2.e001297.4","doi-asserted-by":"crossref","unstructured":"Gunnoo T , Hasan N , Khan MS , et al . Quantifying the risk of heart disease following acute ischaemic stroke. BMJ Open 2016.:6. doi:10.1136\/bmjopen-2015-009535","DOI":"10.1136\/bmjopen-2015-009535"},{"key":"2025100523201345000_7.2.e001297.5","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.167.22.2417"},{"key":"2025100523201345000_7.2.e001297.6","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000024"},{"key":"2025100523201345000_7.2.e001297.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31942-1"},{"key":"2025100523201345000_7.2.e001297.8","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-010-1629-x"},{"key":"2025100523201345000_7.2.e001297.9","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afaa219"},{"key":"2025100523201345000_7.2.e001297.10","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-013-0095-7"},{"key":"2025100523201345000_7.2.e001297.11","doi-asserted-by":"crossref","first-page":"104450","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.104450","article-title":"Life expectancy after stroke based on age, sex, and rankin grade of disability: a synthesis","volume":"28","author":"Shavelle","year":"2019","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2025100523201345000_7.2.e001297.12","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.111.636233"},{"key":"2025100523201345000_7.2.e001297.13","doi-asserted-by":"crossref","first-page":"1347476","DOI":"10.3389\/fpsyt.2024.1347476","article-title":"Role of frailty in predicting outcomes after stroke: a systematic review and meta-analysis","volume":"15","author":"Li","year":"2024","journal-title":"Front Psychiatry"},{"key":"2025100523201345000_7.2.e001297.14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.13.1711"},{"key":"2025100523201345000_7.2.e001297.15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jamainternmed.2020.6084","article-title":"Evaluation of time to benefit of statins for the primary prevention of cardiovascular events in adults aged 50 to 75 years","volume":"181","author":"Yourman","year":"2021","journal-title":"JAMA Intern Med"},{"key":"2025100523201345000_7.2.e001297.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2009.11.008"},{"key":"2025100523201345000_7.2.e001297.17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01545-8"},{"key":"2025100523201345000_7.2.e001297.18","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61965-6"},{"key":"2025100523201345000_7.2.e001297.19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jacl.2020.10.007","article-title":"Association between statin use and cognitive function: a systematic review of randomized clinical trials and observational studies","volume":"15","author":"Adhikari","year":"2021","journal-title":"J Clin Lipidol"},{"key":"2025100523201345000_7.2.e001297.20","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/jcm12123960","article-title":"Risk of polypharmacy and its outcome in terms of drug interaction in an elderly population: a retrospective cross-sectional study","volume":"12","author":"Alhumaidi","year":"2023","journal-title":"J Clin Med"},{"key":"2025100523201345000_7.2.e001297.21","doi-asserted-by":"crossref","DOI":"10.3390\/medicina56070320","article-title":"Pharmacological interactions in the elderly","volume":"56","author":"B\u0142eszy\u0144ska","year":"2020","journal-title":"Medicina (Kaunas)"},{"key":"2025100523201345000_7.2.e001297.22","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.cnur.2017.04.007","article-title":"Polypharmacy and medication management in older adults","volume":"52","author":"Kim","year":"2017","journal-title":"Nurs Clin North Am"},{"key":"2025100523201345000_7.2.e001297.23","doi-asserted-by":"crossref","first-page":"S325","DOI":"10.2337\/dcS13-2038","article-title":"Intolerance to statins: mechanisms and management","volume":"36 Suppl 2","author":"Bitzur","year":"2013","journal-title":"Diabetes Care"},{"key":"2025100523201345000_7.2.e001297.24","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.118.312782"},{"key":"2025100523201345000_7.2.e001297.25","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcp093"},{"key":"2025100523201345000_7.2.e001297.26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/ageing\/afab282","article-title":"Clinical trials in older people","volume":"51","author":"Pitkala","year":"2022","journal-title":"Age Ageing"},{"key":"2025100523201345000_7.2.e001297.27","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2011.501"},{"key":"2025100523201345000_7.2.e001297.28","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1161\/STROKEAHA.120.030755","article-title":"Statins after ischemic stroke in the oldest: a cohort study using the clinical practice research datalink database","volume":"52","author":"Lefeber","year":"2021","journal-title":"Stroke"},{"key":"2025100523201345000_7.2.e001297.29","doi-asserted-by":"crossref","first-page":"110989","DOI":"10.1016\/j.jocn.2024.110989","article-title":"Statins\u2019 effect on quality of life and functioning in older stroke patients: Systematic review and meta-analysis","volume":"132","author":"Prins","year":"2025","journal-title":"J Clin Neurosci"},{"key":"2025100523201345000_7.2.e001297.30","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1001\/jamainternmed.2015.0289","article-title":"Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness","volume":"175","author":"Kutner","year":"2015","journal-title":"JAMA Intern Med"},{"key":"2025100523201345000_7.2.e001297.31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2009.00531.x"},{"key":"2025100523201345000_7.2.e001297.32","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000625"},{"key":"2025100523201345000_7.2.e001297.33","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab484"},{"key":"2025100523201345000_7.2.e001297.34","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-3-201302050-00583"},{"key":"2025100523201345000_7.2.e001297.35","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.050051"},{"key":"2025100523201345000_7.2.e001297.36","doi-asserted-by":"crossref","unstructured":"Church S , Rogers E , Rockwood K , et al . A scoping review of the clinical frailty scale. BMC Geriatr 2020;20. doi:10.1186\/s12877-020-01801-7","DOI":"10.1186\/s12877-020-01801-7"},{"key":"2025100523201345000_7.2.e001297.37","unstructured":"NVN . Secundaire preventie na tia of herseninfarct. n.d."},{"key":"2025100523201345000_7.2.e001297.38","unstructured":"Multidisciplinaire richtlijn cardiovasculair risicomanagement (CVRM). 2019."},{"key":"2025100523201345000_7.2.e001297.39","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.115.010898"},{"key":"2025100523201345000_7.2.e001297.40","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1212\/WNL.0000000000002652","article-title":"The PROMIS physical function scale: a promising scale for use in patients with ischemic stroke","volume":"86","author":"Katzan","year":"2016","journal-title":"Neurology (ECronicon)"},{"key":"2025100523201345000_7.2.e001297.41","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000258355.23810.c6"},{"key":"2025100523201345000_7.2.e001297.42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2005.53221.x"},{"key":"2025100523201345000_7.2.e001297.43","doi-asserted-by":"crossref","unstructured":"Katz MJ , Wang C , Nester CO , et al . T-MoCA: a valid phone screen for cognitive impairment in diverse community samples. Alzheimers Dement (Amst) 2021;13. doi:10.1002\/dad2.12144","DOI":"10.1002\/dad2.12144"},{"key":"2025100523201345000_7.2.e001297.44","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-017-0541-1"},{"key":"2025100523201345000_7.2.e001297.45","doi-asserted-by":"crossref","unstructured":"Lutomski JE , Baars MAE , Schalk BWM , et al . The development of the Older Persons and Informal Caregivers Survey Minimum DataSet (TOPICS-MDS): a large-scale data sharing initiative. PLoS One 2013;8. doi:10.1371\/journal.pone.0081673","DOI":"10.1371\/journal.pone.0081673"},{"key":"2025100523201345000_7.2.e001297.46","doi-asserted-by":"crossref","unstructured":"Lam KH , Kwa VIH . Validity of the PROMIS-10 Global Health assessed by telephone and on paper in minor stroke and transient ischaemic attack in the Netherlands. BMJ Open 2018;8. doi:10.1136\/bmjopen-2017-019919","DOI":"10.1136\/bmjopen-2017-019919"},{"key":"2025100523201345000_7.2.e001297.47","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-200305000-00004"},{"key":"2025100523201345000_7.2.e001297.48","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.106.481465"},{"key":"2025100523201345000_7.2.e001297.49","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1253\/circj.CJ-18-0346","article-title":"Two-year survival after first-ever stroke in a general population of 1.4 million Japanese\u3000- Shiga stroke registry","volume":"82","author":"Takashima","year":"2018","journal-title":"Circ J"},{"key":"2025100523201345000_7.2.e001297.50","doi-asserted-by":"crossref","unstructured":"Yousufuddin M , Young N , Keenan L , et al . Effect of early hospital readmission and comorbid conditions on subsequent long-term mortality after transient ischemic attack. Brain Behav 2017;7. doi:10.1002\/brb3.865","DOI":"10.1002\/brb3.865"},{"key":"2025100523201345000_7.2.e001297.51","doi-asserted-by":"crossref","first-page":"I","DOI":"10.1177\/23969873221100032","article-title":"European Stroke Organisation (ESO) guideline on pharmacological interventions for long-term secondary prevention after ischaemic stroke or transient ischaemic attack","volume":"7","author":"Dawson","year":"2022","journal-title":"Eur Stroke J"},{"key":"2025100523201345000_7.2.e001297.52","unstructured":"Wang H . Sample size calculations in clinical research. In: Chapman & Hall\/CRC Biostatistics Series. 2nd edn. 2008: 177."},{"key":"2025100523201345000_7.2.e001297.53","doi-asserted-by":"crossref","unstructured":"Guo Y , Logan HL , Glueck DH , et al . Selecting a sample size for studies with repeated measures. BMC Med Res Methodol 2013;13. doi:10.1186\/1471-2288-13-100","DOI":"10.1186\/1471-2288-13-100"},{"key":"2025100523201345000_7.2.e001297.54","unstructured":"Vektis . Zorginformatie. n.d. Available: https:\/\/www.vektis.nl"},{"key":"2025100523201345000_7.2.e001297.55","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jphys.2024.10.003","article-title":"Research Note: economic evaluations in physiotherapy","volume":"71","author":"van Dongen","year":"2025","journal-title":"J Physiother"},{"key":"2025100523201345000_7.2.e001297.56","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1002\/hec.4603","article-title":"A scoping review of statistical methods for trial-based economic evaluations: the current state of play","volume":"31","author":"El Alili","year":"2022","journal-title":"Health Econ"},{"key":"2025100523201345000_7.2.e001297.57","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.21383"},{"key":"2025100523201345000_7.2.e001297.58","unstructured":"OECD . Netherlands: country health profile. 2021."},{"key":"2025100523201345000_7.2.e001297.59","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Pineda A , Martinez-Mu\u00f1oz M , Nouni-Garc\u00eda R , et al . Methods and validity indicators for measuring adherence to statins in secondary cardiovascular prevention: a systematic review. Syst Rev 2025;14. doi:10.1186\/s13643-025-02853-9","DOI":"10.1186\/s13643-025-02853-9"}],"container-title":["BMJ Neurology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjno-2025-001297","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:20:26Z","timestamp":1759731626000},"score":1,"resource":{"primary":{"URL":"https:\/\/neurologyopen.bmj.com\/lookup\/doi\/10.1136\/bmjno-2025-001297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":59,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,10,5]]},"published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1136\/bmjno-2025-001297"],"URL":"https:\/\/doi.org\/10.1136\/bmjno-2025-001297","relation":{},"ISSN":["2632-6140"],"issn-type":[{"value":"2632-6140","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}